Jim Simons Aytu Biopharma, Inc Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.15 - $4.0 $58,989 - $1.57 Million	393,262 Added 22.5%	2,140,782 $405,000
Q3 2022 Nov 14, 2022	BUY	$0.19 - $3.8 $131,430 - $2.63 Million	691,738 Added 65.52%	1,747,520 $323,000
Q2 2022 Aug 12, 2022	BUY	$0.46 - $1.08 $133,543 - $313,538	290,313 Added 37.93%	1,055,782 $728,000
Q1 2022 May 13, 2022	BUY	$1.08 - $1.55 $108,432 - $155,620	100,400 Added 15.1%	765,469 $827,000
Q4 2021 Feb 11, 2022	BUY	$1.35 - $2.95 $6,027 - $13,171	4,465 Added 0.68%	665,069 $898,000
Q3 2021 Nov 12, 2021	BUY	$2.78 - $5.12 $509,393 - $938,163	183,235 Added 38.38%	660,604 $1.9 Million
Q2 2021 Aug 13, 2021	BUY	$4.73 - $7.56 $1.64 Million - $2.62 Million	346,848 Added 265.74%	477,369 $2.39 Million
Q1 2021 May 13, 2021	BUY	$6.23 - $9.88 $813,145 - $1.29 Million	130,521 New	130,521 $992,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $88.7M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.